# MDT — Medtronic · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** MDT  
**Sources:** 18  
**Published:** 2026-10-03  
**Canonical:** https://app.k3vl4r.com/research/deep-research-mdt-medtronic-catalysts-narrative-risks-5762

---

# Medtronic plc (NYSE: MDT) — Research Snapshot as of October 3, 2026

*Background (unverified from our own files): NYSE-listed; filed under medical_devices. Medtronic is an Irish-domiciled company (ISIN IE00BTN1Y115) with operational headquarters in Minneapolis, Minnesota, and a fiscal year ending in late April [[2]](https://www.ad-hoc-news.de/boerse/news/corporate-news/medtronic-raises-fiscal-2027-outlook-for-medtronic-stock/70209383), [[17]](https://en.wikipedia.org/wiki/Medtronic). It is the world's largest medical device company by revenue [[17]](https://en.wikipedia.org/wiki/Medtronic).*

## 1. Recent Catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-mdt-medtronic-catalysts-narrative-risks-5762 (free to sign up)._
